107 related articles for article (PubMed ID: 23667941)
1. Melanoma resistance gene identified.
Bond T
Biomark Med; 2013 Apr; 7(2):199. PubMed ID: 23667941
[No Abstract] [Full Text] [Related]
2. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets.
Grossman D; Altieri DC
Cancer Metastasis Rev; 2001; 20(1-2):3-11. PubMed ID: 11831644
[TBL] [Abstract][Full Text] [Related]
3. The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells.
Chin MY; Ng KC; Li G
Exp Cell Res; 2005 Apr; 304(2):531-43. PubMed ID: 15748897
[TBL] [Abstract][Full Text] [Related]
4. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
[TBL] [Abstract][Full Text] [Related]
5. Death receptors and melanoma resistance to apoptosis.
Ivanov VN; Bhoumik A; Ronai Z
Oncogene; 2003 May; 22(20):3152-61. PubMed ID: 12789291
[TBL] [Abstract][Full Text] [Related]
6. Role of apaf-1 in melanoma drug resistance and apoptosis.
Röckmann H; Schadendorf D
J Invest Dermatol; 2005 Aug; 125(2):386-7. PubMed ID: 16098052
[No Abstract] [Full Text] [Related]
7. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma.
Knopf A; Plettenberg C; Pickhard A; Bas M; Reifenberger J; Bier H; Balz V
Melanoma Res; 2011 Oct; 21(5):380-8. PubMed ID: 21691232
[TBL] [Abstract][Full Text] [Related]
9. Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status.
Hammerová J; Uldrijan S; Táborská E; Slaninová I
J Dermatol Sci; 2011 Apr; 62(1):22-35. PubMed ID: 21324654
[TBL] [Abstract][Full Text] [Related]
10. [Living and letting die--new mechanisms of apoptosis resistance in melanoma cells]].
Hautarzt; 2001 Apr; 52(4):386-7. PubMed ID: 11382133
[No Abstract] [Full Text] [Related]
11. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
12. Molecularly targeted therapy for melanoma: current reality and future options.
Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
[TBL] [Abstract][Full Text] [Related]
13. P53 in skin cancer: From a master player to a privileged target for prevention and therapy.
Loureiro JB; Abrantes M; Oliveira PA; Saraiva L
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188438. PubMed ID: 32980466
[TBL] [Abstract][Full Text] [Related]
14. Impaired PIASy-Tip60 signaling weakens activation of p53 in melanoma.
Lakhter AJ; Kanginakudru S; Warren S; Touloukian CE; Boissy RE; Naidu SR
Melanoma Res; 2013 Jun; 23(3):213-7. PubMed ID: 23624367
[TBL] [Abstract][Full Text] [Related]
15. Selection for TRAIL resistance results in melanoma cells with high proliferative potential.
Wu JJ; Zhang XD; Gillespie S; Hersey P
FEBS Lett; 2005 Mar; 579(9):1940-4. PubMed ID: 15792800
[TBL] [Abstract][Full Text] [Related]
16. The genetics of skin cancer.
Tsai KY; Tsao H
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):82-92. PubMed ID: 15468170
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for melanoma: the resultant of conflicting vectors.
Mitchell MS
J Clin Oncol; 2004 Jun; 22(11):2043-5. PubMed ID: 15123732
[No Abstract] [Full Text] [Related]
18. [Genetic basis of malignant melanoma].
Drewa G; Powierska-Czarny J
Postepy Hig Med Dosw; 1998; 52(4):367-80. PubMed ID: 9780757
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma.
Nickoloff BJ; Vande Woude G
Pigment Cell Melanoma Res; 2012 Nov; 25(6):758-61. PubMed ID: 22974232
[No Abstract] [Full Text] [Related]
20. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
